Sophia Zoungas
Sophia Zoungas
Professor and Head, School of Public Health and Preventive Medicine, Monash University, VIC.
Verified email at monash.edu
Title
Cited by
Cited by
Year
Severe hypoglycemia and risks of vascular events and death
S Zoungas, A Patel, J Chalmers, BE De Galan, Q Li, L Billot, M Woodward, ...
New England Journal of Medicine 363 (15), 1410-1418, 2010
13422010
Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects
Y Ben-Shlomo, M Spears, C Boustred, M May, SG Anderson, EJ Benjamin, ...
Journal of the American College of Cardiology 63 (7), 636-646, 2014
11132014
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ...
Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009
8272009
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ...
New England Journal of Medicine 371 (15), 1392-1406, 2014
5562014
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
HJL Heerspink, T Ninomiya, S Zoungas, D de Zeeuw, DE Grobbee, ...
The Lancet 373 (9668), 1009-1015, 2009
4562009
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: new results from …
S Zoungas, BE De Galan, T Ninomiya, D Grobbee, P Hamet, S Heller, ...
Diabetes care 32 (11), 2068-2074, 2009
3352009
Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the …
International Hypoglycaemia Study Group
Diabetes care 40 (1), 155-157, 2017
3172017
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
V Perkovic, HL Heerspink, J Chalmers, M Woodward, M Jun, Q Li, ...
Kidney international 83 (3), 517-523, 2013
2802013
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
S Zoungas, J Chalmers, T Ninomiya, Q Li, ME Cooper, S Colagiuri, ...
Diabetologia 55 (3), 636-643, 2012
2802012
Diabetes and hypertension: a position statement by the American Diabetes Association
IH De Boer, S Bangalore, A Benetos, AM Davis, ED Michos, P Muntner, ...
Diabetes Care 40 (9), 1273-1284, 2017
2772017
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial
S Zoungas, BP McGrath, P Branley, PG Kerr, C Muske, R Wolfe, ...
Journal of the American College of Cardiology 47 (6), 1108-1116, 2006
2692006
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
S Zoungas, M Woodward, Q Li, ME Cooper, P Hamet, S Harrap, S Heller, ...
Diabetologia 57 (12), 2465-2474, 2014
2312014
Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy
S Zoungas, T Ninomiya, R Huxley, A Cass, M Jardine, M Gallagher, ...
Annals of internal medicine 151 (9), 631-638, 2009
2032009
Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial
Y Hirakawa, H Arima, S Zoungas, T Ninomiya, M Cooper, P Hamet, ...
Diabetes care 37 (8), 2359-2365, 2014
2002014
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron …
BE De Galan, S Zoungas, J Chalmers, C Anderson, C Dufouil, A Pillai, ...
Diabetologia 52 (11), 2328-2336, 2009
1902009
Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial
MJ Jardine, T Ninomiya, V Perkovic, A Cass, F Turnbull, MP Gallagher, ...
Journal of the American College of Cardiology 56 (12), 956-965, 2010
1862010
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis
SC Palmer, L Di Micco, M Razavian, JC Craig, V Perkovic, F Pellegrini, ...
Annals of internal medicine 156 (6), 445-459, 2012
1822012
Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
S Zoungas, H Arima, HC Gerstein, RR Holman, M Woodward, P Reaven, ...
The lancet Diabetes & endocrinology 5 (6), 431-437, 2017
1802017
Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial
J Hata, H Arima, PM Rothwell, M Woodward, S Zoungas, C Anderson, ...
Circulation 128 (12), 1325-1334, 2013
1582013
Diabetic kidney disease
MC Thomas, M Brownlee, K Susztak, K Sharma, KAM Jandeleit-Dahm, ...
Nature Reviews Disease Primers 1 (1), 1-20, 2015
1442015
The system can't perform the operation now. Try again later.
Articles 1–20